← Community

Opportunities

[Closed - deadline Nov 18] Pharma and medtech sales professionals: $100 gift card for a 60-minute remote session testing an AI role-play tool (QFW)

Puper

Author · Posted

Original language: English

Replies
0
Views
0
Latest replyNo replies yetView discussion →
The deadline listed by the author has passed. Check the source page to see whether the offer is still available.
Region
Not specified
Reward
$100 digital gift card (choice of brands, via User Interviews)
Required spending
Not specified
Deadline
18 Nov 2026, 18:29 UTC
Last checked by author
19 Nov 2026, 02:35 UTC
Commercial relationship
Shared from a public User Interviews listing. No sponsorship, referral or relationship with QFW or User Interviews.

This information was provided by the author. Check the source page for the latest terms before taking part.

Status update (checked November 19, 2026): the application deadline (November 18, 2026) has passed, so treat this study as closed. The details below are kept for reference.

QFW builds AI practice tools for pharma and medtech sales teams and wants your reactions to a set of practice calls.

In one remote sitting of about 60 minutes, you'll do short practice calls with an AI (about 10–15 minutes each). Depending on your role, the AI plays either a sales rep or a healthcare professional, and you respond as you normally would at work. Afterwards you share how it went. The listing says no preparation is needed, the calls are recorded for their team to review, and they want honest reactions rather than to test you.

  • Reward: $100, paid as your choice of digital gift cards through User Interviews
  • Device: a laptop or desktop with a working microphone and camera (the listing also flags audio, video and screen)
  • Sessions: November 4 to 18, 2026
  • Applications close: November 18, 2026 at 23:59 (UTC+5:30)

There's a screener first, so applying doesn't guarantee a session.

Apply here: QFW AI role-play tool study on User Interviews

Sign in to join the discussion

Discussion

No replies yet. Start the conversation.

Sign in to reply